FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186286502> ?p ?o ?g. }

• W3186286502 endingPage "175628642110195" @default.
• W3186286502 startingPage "175628642110195" @default.
• W3186286502 abstract "Infectious diseases are an important consideration in autoimmune conditions such as multiple sclerosis. Infective episodes may trigger relapses and significantly deteriorate the course of the disease. Some immunotherapies may cause increased rates of infection-related adverse events. Thus, infection and vaccine-related issues should be included in the individualized patient-specific treatment strategy and counseling before starting therapy and regularly on treatment. Clinical and epidemiological studies as well as pharmacovigilance data repeatedly demonstrated the safety of the great majority of vaccines in multiple sclerosis patients. Moreover, studies have shown that vaccinations with killed/inactivated vaccines do not increase the short-term risk of relapse or deterioration in multiple sclerosis, whereas infections have been shown to provoke relapses. The available evidence indicates reduced humoral vaccination efficacy on treatment with MS drugs acting on the S1P receptor, natalizumab, and B-cell depleting therapies. Recent data for cladribine tablets suggest the potential of effective immunization in the interval of the two treatment courses and after completion of therapy. Regardless of treatment, vaccine efficacy may be optimized with proper timing of application. Multiple sclerosis patients receiving highly effective therapies should be vaccinated according to general recommendations for healthy adults. Immunization against COVID-19 is highly recommended for all multiple sclerosis patients regardless of age and comorbidities. Preliminary data show the potential of adequate responses in patients treated with cladribine tablets." @default.
• W3186286502 created "2021-08-02" @default.
• W3186286502 creator A5003159414 @default.
• W3186286502 creator A5038373894 @default.
• W3186286502 creator A5043382646 @default.
• W3186286502 creator A5055558719 @default.
• W3186286502 creator A5062220148 @default.
• W3186286502 creator A5062744631 @default.
• W3186286502 creator A5063615479 @default.
• W3186286502 creator A5067069046 @default.
• W3186286502 creator A5084494517 @default.
• W3186286502 creator A5087329759 @default.
• W3186286502 date "2021-01-01" @default.
• W3186286502 modified "2023-10-02" @default.
• W3186286502 title "Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets" @default.
• W3186286502 cites W1975897195 @default.
• W3186286502 cites W1976033149 @default.
• W3186286502 cites W1999381942 @default.
• W3186286502 cites W2023943842 @default.
• W3186286502 cites W2033366028 @default.
• W3186286502 cites W2052130188 @default.
• W3186286502 cites W2074262343 @default.
• W3186286502 cites W2079737165 @default.
• W3186286502 cites W2080994119 @default.
• W3186286502 cites W2109310943 @default.
• W3186286502 cites W2114494341 @default.
• W3186286502 cites W2124598981 @default.
• W3186286502 cites W2160358721 @default.
• W3186286502 cites W2167731608 @default.
• W3186286502 cites W2327614140 @default.
• W3186286502 cites W2333997132 @default.
• W3186286502 cites W2514636267 @default.
• W3186286502 cites W2754801076 @default.
• W3186286502 cites W2765903850 @default.
• W3186286502 cites W2769546943 @default.
• W3186286502 cites W2771951908 @default.
• W3186286502 cites W2882999132 @default.
• W3186286502 cites W2900596677 @default.
• W3186286502 cites W2910867209 @default.
• W3186286502 cites W2911523051 @default.
• W3186286502 cites W2914815144 @default.
• W3186286502 cites W2926499529 @default.
• W3186286502 cites W2926740446 @default.
• W3186286502 cites W2963064076 @default.
• W3186286502 cites W2970828189 @default.
• W3186286502 cites W2973312583 @default.
• W3186286502 cites W2990401858 @default.
• W3186286502 cites W2999448559 @default.
• W3186286502 cites W3002777976 @default.
• W3186286502 cites W3021074489 @default.
• W3186286502 cites W3045825841 @default.
• W3186286502 cites W3046680555 @default.
• W3186286502 cites W3048269933 @default.
• W3186286502 cites W3048832522 @default.
• W3186286502 cites W3080204060 @default.
• W3186286502 cites W3093024582 @default.
• W3186286502 cites W3096319326 @default.
• W3186286502 cites W3158831599 @default.
• W3186286502 doi "https://doi.org/10.1177/17562864211019598" @default.
• W3186286502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8521756" @default.
• W3186286502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34671422" @default.
• W3186286502 hasPublicationYear "2021" @default.
• W3186286502 type Work @default.
• W3186286502 sameAs 3186286502 @default.
• W3186286502 citedByCount "10" @default.
• W3186286502 countsByYear W31862865022021 @default.
• W3186286502 countsByYear W31862865022022 @default.
• W3186286502 countsByYear W31862865022023 @default.
• W3186286502 crossrefType "journal-article" @default.
• W3186286502 hasAuthorship W3186286502A5003159414 @default.
• W3186286502 hasAuthorship W3186286502A5038373894 @default.
• W3186286502 hasAuthorship W3186286502A5043382646 @default.
• W3186286502 hasAuthorship W3186286502A5055558719 @default.
• W3186286502 hasAuthorship W3186286502A5062220148 @default.
• W3186286502 hasAuthorship W3186286502A5062744631 @default.
• W3186286502 hasAuthorship W3186286502A5063615479 @default.
• W3186286502 hasAuthorship W3186286502A5067069046 @default.
• W3186286502 hasAuthorship W3186286502A5084494517 @default.
• W3186286502 hasAuthorship W3186286502A5087329759 @default.
• W3186286502 hasBestOaLocation W31862865021 @default.
• W3186286502 hasConcept C126322002 @default.
• W3186286502 hasConcept C177713679 @default.
• W3186286502 hasConcept C197934379 @default.
• W3186286502 hasConcept C203014093 @default.
• W3186286502 hasConcept C22070199 @default.
• W3186286502 hasConcept C2776036978 @default.
• W3186286502 hasConcept C2778577042 @default.
• W3186286502 hasConcept C2779134260 @default.
• W3186286502 hasConcept C2779200787 @default.
• W3186286502 hasConcept C2780640218 @default.
• W3186286502 hasConcept C2780801004 @default.
• W3186286502 hasConcept C2781004633 @default.
• W3186286502 hasConcept C57658597 @default.
• W3186286502 hasConcept C71924100 @default.
• W3186286502 hasConcept C8891405 @default.
• W3186286502 hasConceptScore W3186286502C126322002 @default.
• W3186286502 hasConceptScore W3186286502C177713679 @default.
• W3186286502 hasConceptScore W3186286502C197934379 @default.

• next